A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Lung cancer is hard to catch early and even harder to survive once it is found. A new clinical trial will test whether a ...

With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...

For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...

We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...

A local lung cancer survivor shares her shocking story of how she was diagnosed with late-stage cancer, caused by elevated ...

Had I known, I would have done this 20 years prior,' Lung cancer survivor shares her story about the importance of testing for radon ...

Barry Manilow gave fans a health update on Jan. 2, saying that he is 'better,' weeks after he revealed that a cancerous spot ...